BerGenBio ASA (BRRGF)
USD 2.5
(0.0%)
USD 2.5
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 354 Thousand | 39.65 Thousand | 87.66 Thousand | 70.19 Thousand | 1.01 Million | 269.65 Thousand |
| Cost of Revenue | - | 0.55 | 0.69 | 10.44 Million | 7.42 Million | 7.67 Million |
| Gross Profit | 354 Thousand | 39.65 Thousand | 87.66 Thousand | -10.37 Million | -6.41 Million | -7.4 Million |
| Operating Expenses | 192.17 Million | 32.17 Million | 37.05 Million | 20.67 Million | 19.2 Million | 17.23 Million |
| Selling, General and Administrative Expenses | - | 10.71 Million | 12.9 Million | 276.1 Thousand | 237.5 Thousand | 2.19 Million |
| Research and Development Expenses | 107.78 Million | 21.46 Million | 24.15 Million | 20.39 Million | 18.96 Million | 15.03 Million |
| Other Expenses | 84.38 Million | - | - | - | - | - |
| Cost and Expenses | 192.17 Million | 32.26 Million | 37.2 Million | 31.12 Million | 26.62 Million | 24.91 Million |
| Operating Income | -191.81 Million | -32.22 Million | -37.12 Million | -31.05 Million | -25.61 Million | -24.64 Million |
| Interest Expense | 578 Thousand | 1.17 Million | 1.23 Million | 1.8 Million | 732.19 Thousand | 723 Thousand |
| Income Tax Expense | - | -299.63 Thousand | -354.49 Thousand | -516.47 Thousand | -257.64 Thousand | 1.00 |
| Earnings before Tax | -190.4 Million | -30.8 Million | -35.03 Million | -30.01 Million | -22.67 Million | -22.14 Million |
| Net Income | -190.4 Million | -30.8 Million | -35.03 Million | -30.01 Million | -22.67 Million | -22.14 Million |
| Earnings Per Share Basic | -13.30 | -34.75 | -34.39 | -34.59 | -0.39 | -4.69 |
| Earnings Per Share Diluted | -13.30 | -34.75 | -34.39 | -34.59 | -0.39 | -4.69 |
| Weighted Average Shares Outstanding | 14.31 Million | 886.36 Thousand | 1.01 Million | 867.75 Thousand | 58.03 Million | 4.72 Million |
| Weighted Average Shares Outstanding (Diluted) | 14.31 Million | 886.36 Thousand | 1.01 Million | 867.75 Thousand | 58.03 Million | 4.72 Million |
| Gross Margin | 1.00 | 1.00 | 1.00 | -147.87 | -6.33 | -27.48 |
| EBIT Margin | -535.59 | -810.22 | -421.76 | -441.21 | -25.20 | -91.30 |
| Profit Margin | -537.86 | -776.67 | -399.70 | -427.67 | -22.39 | -82.12 |
| EBITDA | -189.6 Million | -32.13 Million | -36.97 Million | -30.97 Million | -25.52 Million | -24.61 Million |
| Earnings Before Tax Margin | -541.86 | -812.49 | -423.45 | -442.42 | -25.29 | -91.39 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | 15.43 Thousand | 34.75 Thousand | 34.75 Thousand | - | - |
| Cost of Revenue | 9825.90 | 1.59 Million | 8.27 Million | 1.64 Million | 10.18 Thousand | 651.42 |
| Gross Profit | -9825.90 | -1.58 Million | -8.23 Million | -1.61 Million | -10.18 Thousand | -651.42 |
| Operating Expenses | 4.84 Million | 2.19 Million | 11.53 Million | 3.21 Million | 2.72 Million | 4.56 Million |
| Selling, General and Administrative Expenses | 1.8 Million | 29.38 Thousand | - | 157.86 Thousand | 1.75 Million | 2.42 Million |
| Research and Development Expenses | 3.04 Million | 2.16 Million | - | 3.05 Million | 965.68 Thousand | 2.14 Million |
| Other Expenses | 3.57 Million | - | - | - | - | - |
| Cost and Expenses | 4.85 Million | 3.79 Million | 19.81 Million | 4.86 Million | 2.73 Million | 4.56 Million |
| Operating Income | -4.85 Million | -3.77 Million | -19.77 Million | -4.83 Million | -2.73 Million | -4.56 Million |
| Interest Expense | 1.35 Million | 707 Thousand | 578 Thousand | -9.11 Million | 366.11 Thousand | 286.71 Thousand |
| Income Tax Expense | -0.90 | -1.00 | -146 Thousand | -0.67 | -380.87 Thousand | -186.86 Thousand |
| Earnings before Tax | -4.65 Million | -3.33 Million | -18.69 Million | -4.08 Million | -2.6 Million | -4.54 Million |
| Net Income | -4.65 Million | -3.33 Million | -18.69 Million | -4.08 Million | -2.6 Million | -4.54 Million |
| Earnings Per Share Basic | -0.13 | -0.12 | - | -0.00 | -0.10 | -1.35 |
| Earnings Per Share Diluted | -0.13 | -0.12 | - | -0.00 | -0.10 | -1.35 |
| Weighted Average Shares Outstanding | 35.86 Million | 26.88 Million | 14.31 Million | - | 26.2 Million | 3.36 Million |
| Weighted Average Shares Outstanding (Diluted) | 35.86 Million | 26.88 Million | 14.31 Million | - | 26.2 Million | 3.36 Million |
| Gross Margin | - | -102.58 | -237.08 | -46.44 | - | - |
| EBIT Margin | - | -244.11 | - | -138.72 | - | - |
| Profit Margin | - | -216.28 | -537.87 | -117.62 | - | - |
| EBITDA | -4.84 Million | -3.76 Million | - | -4.82 Million | -2.72 Million | -4.56 Million |
| Earnings Before Tax Margin | - | -244.74 | -569.05 | -139.01 | - | - |
NTQ
DBX
6804
JBTC
ACST
376300